141
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

YAP Activates STAT3 Signalling to Promote Colonic Epithelial Cell Proliferation in DSS-Induced Colitis and Colitis Associated Cancer

, ORCID Icon, ORCID Icon & ORCID Icon
Pages 5471-5482 | Received 02 Jun 2022, Accepted 15 Sep 2022, Published online: 19 Sep 2022

References

  • Kobayashi T, Siegmund B, Le Berre C., et al. Ulcerative colitis. Nat Rev Dis Primers. 2020;6(1):74. doi:10.1038/s41572-020-0205-x
  • Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. The Lancet. 2017;390(10114):2769–2778. doi:10.1016/S0140-6736(17)32448-0
  • Ordás I, Eckmann L, Talamini M, et al. Ulcerative colitis. Lancet. 2012;380(9853):1606–1619. doi:10.1016/S0140-6736(12)60150-0
  • Van Der Kraak L, Gros P, Beauchemin N. Colitis-associated colon cancer: is it in your genes? World J Gastroenterol. 2015;21:11688–11699. doi:10.3748/wjg.v21.i41.11688
  • Bopanna S, Ananthakrishnan AN, Kedia S, et al. Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2(4):269–276. doi:10.1016/S2468-1253(17)30004-3
  • Krishnan K, Arnone B, Buchman A. Intestinal growth factors: potential use in the treatment of inflammatory bowel disease and their role in mucosal healing. Inflamm Bowel Dis. 2011;17(1):410–422. doi:10.1002/ibd.21316
  • Wetwittayakhlang P, Lontai L, Gonczi L, et al. Treatment Targets in Ulcerative Colitis: is It Time for All In, including Histology? J Clin Med. 2021;10(23):5551. doi:10.3390/jcm10235551
  • Yagi S, Furukawa S. Effect of disease duration on the association between serum albumin and mucosal healing in patients with ulcerative colitis. BMJ. 2021;8:548.
  • Yu FX, Zhao B, Guan KL. Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer. Cell. 2015;163:811–828. doi:10.1016/j.cell.2015.10.044
  • Dey A, Varelas X, Guan KL. Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine. Nat Rev Drug Discov. 2020;19:480–494. doi:10.1038/s41573-020-0070-z
  • Watt KI, Harvey KF, Gregorevic P. Regulation of Tissue Growth by the Mammalian Hippo Signaling Pathway. Front Physiol. 2017;8:942. doi:10.3389/fphys.2017.00942
  • Totaro A, Panciera T, Piccolo S. YAP/TAZ upstream signals and downstream responses. Nat Cell Biol. 2018;20(8):888–899. doi:10.1038/s41556-018-0142-z
  • Kim MK, Jang JW, Bae SC. DNA binding partners of YAP/TAZ. BMB Rep. 2018;51:126–133. doi:10.5483/BMBRep.2018.51.3.015
  • Labibi B, Bashkurov M, Wrana JL, et al. Modeling the Control of TGF-beta/Smad Nuclear Accumulation by the Hippo Pathway Effectors, Taz/Yap. iScience. 2020;23:101416. doi:10.1016/j.isci.2020.101416
  • Zhou D, Zhang Y, Wu H, et al. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci U S A. 2011;108(49):E1312–20. doi:10.1073/pnas.1110428108
  • Cai J, Zhang N, Zheng Y, et al. The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev. 2010;24(21):2383–2388. doi:10.1101/gad.1978810
  • Romera-Hernandez M, Aparicio-Domingo P, Papazian N, et al. Yap1-Driven Intestinal Repair Is Controlled by Group 3 Innate Lymphoid Cells. Cell Rep. 2020;30(1):37–45 e3. doi:10.1016/j.celrep.2019.11.115
  • Katakura K, Lee J, Rachmilewitz D, et al. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest. 2005;115:695–702. doi:10.1172/JCI22996
  • Lu J, Liu D, Tan Y, et al. Thalidomide Attenuates Colitis and Is Associated with the Suppression of M1 Macrophage Polarization by Targeting the Transcription Factor IRF5. Dig Dis Sci. 2021;66(11):3803–3812. doi:10.1007/s10620-021-07067-2
  • Daley SK, Witte MH, Washington J, et al. Role of Lymphatic Deficiency in the Pathogenesis and Progression of Inflammatory Bowel Disease to Colorectal Cancer in an Experimental Mouse Model. Inflamm Bowel Dis. 2019;25(12):1919–1926. doi:10.1093/ibd/izz112
  • Xu J, Zheng C, Huang Y, et al. Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism. Chin Med J. 2014;127:2368–2375.
  • Guma M, Stepniak D, Shaked H, et al. Constitutive intestinal NF-κB does not trigger destructive inflammation unless accompanied by MAPK activation. J Exp Med. 2011;208(9):1889–1900. doi:10.1084/jem.20110242
  • Miyoshi H, Ajima R, Luo CT, et al. Wnt5a potentiates TGF-beta signaling to promote colonic crypt regeneration after tissue injury. Science. 2012;338:108–113. doi:10.1126/science.1223821
  • Barrett TA. Developmental biology. Intestinal wound healing requires a Wnt balancing act. Science. 2012;338(6103):51–52. doi:10.1126/science.1229414
  • Hu YS, Han X, Liu XH. STAT3: a Potential Drug Target for Tumor and Inflammation. Curr Top Med Chem. 2019;19(15):1305–1317. doi:10.2174/1568026619666190620145052
  • Tolomeo M, Cascio A. The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy. Int J Mol Sci. 2021;22. doi:10.3390/ijms23010022
  • Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009;9:798–809. doi:10.1038/nrc2734
  • He L, Pratt H, Gao M. YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation. BMJ. 2021;10;325.
  • Chen B, Yang Y, Wu J, et al. microRNA-17-5p downregulation inhibits autophagy and myocardial remodelling after myocardial infarction by targeting STAT3. Autoimmunity. 2021:1;1–9.
  • Park R, Moon UY, Park JY, et al. Yap is required for ependymal integrity and is suppressed in LPA-induced hydrocephalus. Nat Commun. 2016;7(1):10329. doi:10.1038/ncomms10329
  • Chen J, Cheng J, Zhao C, et al. The Hippo pathway: a renewed insight in the craniofacial diseases and hard tissue remodeling. Int J Biol Sci. 2021;17(14):4060–4072. doi:10.7150/ijbs.63305
  • Johnson R, Halder G. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discov. 2014;13(1):63–79. doi:10.1038/nrd4161
  • Moya IM, Halder G. Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine. Nature Reviews. Molecular Cell Biology. 2019;20(4):211–226. doi:10.1038/s41580-018-0086-y
  • Li Y, Ge L, Chen X, et al. The common YAP activation mediates corneal epithelial regeneration and repair with different-sized wounds. NPJ Regen Med. 2021;6(1):16. doi:10.1038/s41536-021-00126-2
  • Gokey JJ, Patel SD, Kropski JA. The Role of Hippo/YAP Signaling in Alveolar Repair and Pulmonary Fibrosis. Front Med. 2021;8:752316. doi:10.3389/fmed.2021.752316
  • LaCanna R, Liccardo D, Zhang P, et al. Yap/Taz regulate alveolar regeneration and resolution of lung inflammation. J Clin Invest. 2019;129(5):2107–2122. doi:10.1172/JCI125014
  • Meng F, Xie B, Martin JF. Targeting the Hippo pathway in heart repair. Cardiovasc Res. 2021;1:6548.
  • Wang H, Song X, Liao H, et al. Overexpression of Mothers Against Decapentaplegic Homolog 7 Activates the Yes-Associated Protein/NOTCH Cascade and Promotes Liver Carcinogenesis in Mice and Humans. Hepatology (Baltimore, Md.). 2021;74(1):248–263. doi:10.1002/hep.31692
  • Jin L, Chen Y, Cheng D, et al. YAP inhibits autophagy and promotes progression of colorectal cancer via upregulating Bcl-2 expression. Cell Death & Disease. 2021;12(5):457. doi:10.1038/s41419-021-03722-8
  • Huynh J, Chand A, Gough D, Ernst M. Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map. Nature Reviews. Cancer. 2019;19(2):82–96. doi:10.1038/s41568-018-0090-8
  • Baht GS, Bareja A, Lee DE, et al. Meteorin-like facilitates skeletal muscle repair through a Stat3/IGF-1 mechanism. Nature Metabolism. 2020;2(3):278–289. doi:10.1038/s42255-020-0184-y
  • Lindemans CA, Calafiore M, Mertelsmann AM, et al. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature. 2015;528(7583):560–564. doi:10.1038/nature16460
  • Paris AJ, Hayer KE, Oved JH. STAT3-BDNF-TrkB signalling promotes alveolar epithelial regeneration after lung injury. Nature Cell Biology. 2020;22(10):1197–1210. doi:10.1038/s41556-020-0569-x
  • Gruber R, Panayiotou R, Nye E, et al. YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK-STAT3 Signaling. Gastroenterology. 2016;151:526–539. doi:10.1053/j.gastro.2016.05.006
  • Du XX, He C, Lu X, et al. YAP/STAT3 promotes the immune escape of larynx carcinoma by activating VEGFR1-TGFbeta signaling to facilitate PD-L1 expression in M2-like TAMs. Exp Cell Res. 2021;405:112655. doi:10.1016/j.yexcr.2021.112655